The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review

The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review

Background Glucagon-like peptide 1 receptor agonists are a class of drug originally developed to treat type 2 diabetes but now increasingly used for weight loss, especially in people living with obesity. Despite an abundance of evidence about the effectiveness and safety of glucagon-like peptide 1 r...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Nunns, Samantha Febrey, Jill Buckland, Rebecca Abbott, Rebecca Whear, Alison Bethel, Kate Boddy, Liz Shaw, Jo Thompson Coon, GJ Melendez-Torres
Format: Article
Language:English
Published: NIHR Journals Library 2025-06-01
Series:Health Technology Assessment
Subjects:
glucagon-like peptide 1 receptor agonists
weight loss
network meta-analysis
safety
scoping review
Online Access:https://doi.org/10.3310/SKHT8119
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://doi.org/10.3310/SKHT8119

Similar Items